Independent Advisor Alliance Humacyte, Inc. Transaction History
Independent Advisor Alliance
- $2.95 Billion
- Q1 2025
A detailed history of Independent Advisor Alliance transactions in Humacyte, Inc. stock. As of the latest transaction made, Independent Advisor Alliance holds 10,492 shares of HUMA stock, worth $24,866. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,492Holding current value
$24,866% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HUMA
# of Institutions
188Shares Held
60.4MCall Options Held
1.05MPut Options Held
877K-
Black Rock Inc. New York, NY7.14MShares$16.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.6MShares$15.6 Million0.0% of portfolio
-
State Street Corp Boston, MA4.27MShares$10.1 Million0.0% of portfolio
-
Heights Capital Management, Inc San Francisco, CA4.03MShares$9.54 Million3.22% of portfolio
-
Woodline Partners LP San Francisco, CA3.95MShares$9.36 Million0.05% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $244M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...